Novolog Sales Data
| Rank 36 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Novolog U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 36 ( 1) |
$344,235 | 3.86% | 2,508 | -2.90% |
| Q3 2013 | 35 ( 5) |
$331,449 | 3.66% | 2,583 | -13.18% |
| Q2 2013 | 40 (2) |
$319,752 | -0.94% | 2,975 | -2.14% |
| Q1 2013 | 42 (3) |
$322,779 | 3.74% | 3,040 | -10.03% |
| Q4 2012 | 39 (5) |
$311,150 | 5.87% | 3,379 | 8.54% |
| Q3 2012 | 44 (10) |
$293,893 | 8.83% | 3,113 | 3.53% |
| Q2 2012 | 54 (3) |
$270,047 | 1.41% | 3,007 | 0.91% |
| Q1 2012 | 57 (6) |
$266,305 | 5.67% | 2,980 | 3.72% |
| Q4 2011 | 63 (3) |
$252,015 | 0.97% | 2,873 | -0.48% |
| Q3 2011 | 60 (1) |
$249,591 | -0.96% | 2,887 | -2.66% |
| Q2 2011 | 61 (5) |
$252,010 | 3.16% | 2,966 | -0.70% |
| Q1 2011 | 66 | $244,297 | n/a | 2,987 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
